Skip to main content
. 2019 Mar 28;3(5):nzz019. doi: 10.1093/cdn/nzz019

TABLE 2.

Adjusted least-square means of change in inflammation and oxidative stress score per averaged dietary protein in quartile categories of intake in 2061 participants of the Framingham Heart Study Offspring cohort1

Quartile category of protein intake2
Dietary intake Model3 Q1 Q2 Q3 Q4 P-trend
Protein, g/d 1 0.766 ± 0.172 0.575 ± 0.176 0.369 ± 0.179 0.310 ± 0.185 0.02
2 0.839 ± 0.258 0.598 ± 0.252 0.362 ± 0.254 0.284 ± 0.252 0.007
3 0.813 ± 0.261 0.583 ± 0.253 0.362 ± 0.254 0.313 ± 0.255 0.02
Animal protein, g/d 1 0.624 ± 0.176 0.655 ± 0.175 0.410 ± 0.176 0.402 ± 0.184 0.19
2 0.651 ± 0.258 0.644 ± 0.251 0.389 ± 0.253 0.360 ± 0.254 0.11
3 0.702 ± 0.261 0.642 ± 0.251 0.362 ± 0.253 0.313 ± 0.258 0.05
Plant protein, g/d 1 0.784 ± 0.170 0.473 ± 0.178 0.524 ± 0.180 0.227 ± 0.183 0.01
2 0.822 ± 0.252 0.479 ± 0.257 0.513 ± 0.253 0.196 ± 0.253 0.006
3 0.891 ± 0.254 0.508 ± 0.257 0.519 ± 0.252 0.141 ± 0.254 0.001
1

Values are least-square adjusted means ± SEs of the outcome, the change in the inflammation and oxidative stress score, modeled as the difference in the score between examination 8 and examination 7. The score is the sum of rank-normalized values of CRP, OPG, ICAM-1, IL-6, MCP-1, LPL-A2 mass and activity, P-selectin, and TNFRII. A higher value of the outcome indicates a larger change (increase) in inflammation/oxidative stress, whereas a lower value indicates a smaller change (increase if positive, decrease if negative), and thus less inflammation/oxidative stress. CRP, C-reactive protein; CVD, cardiovascular disease; ICAM-1, soluble intracellular adhesion molecule 1; LPL-A2, lipoprotein phospholipase A2; MCP-1, monocyte chemoattractant protein 1; NSAID, nonsteroidal anti-inflammatory drug; OPG, osteoprotegerin; TNFRII, tumor necrosis factor receptor II.

2

Median values in quartile categories of intake were as follows: for total protein, 67.4, 77.3, 85.0, and 95.9 g/d; for animal protein, 42.6, 52.5, 60.3, and 71.6 g/d; and for plant protein, 19.8, 22.9, 25.5, and 29.9 g/d.

3

Models were adjusted as follows: 1) age, sex, energy intake, smoking status, and the baseline (examination 7) value of the score; 2) baseline physical activity, NSAID use, BMI, cardiovascular disease history, treatment for hypertension, diabetes, or dyslipidemia, and alcohol intake; 3) glycemic index, and the PUFA:SFA ratio. For animal and plant protein, model 3 was also adjusted for the other protein source (e.g., animal protein adjusted for plant protein as well as glycemic index and the PUFA:SFA ratio).